Updated clinical data may significantly impact treatment of CLL - Jeff Sharman

Updated clinical data may significantly impact treatment of CLL - Jeff Sharman

Here is yet another video interview with Dr Jeff Sharman about how information presented at ASH2014 is anticipated to impact CLL treatment. Here he discusses the impact of idelalisib and ibrutinib on the treatment of relapsed patients and the relevance of FCR treatment in the older population:

healio.com/hematology-oncol...

Neil

Last edited by
oldestnewest

You may also like...